Rabia Owais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rabia Owais has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Asim Shaikh
Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA
1 shared publication - Ayesha Azhar
Department of Internal Medicine, Dow University of Health Sciences
1 shared publication - Ayesha Sheikh
Department of Medicine, Dow Medical College, Karachi, Pakistan
1 shared publication - Eman Ali
Dow University of Health Sciences, Karachi, Pakistan
1 shared publication Maham Iqbal
Dow Univ Hlth Sci, Karachi, Pakistan
1 shared publication- Muskan Asim Taimuri
Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication
Latest Publications
- 4 September 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 193 (2) , 831-832
Potential of near-infrared spectroscopy (NIRS) as a non-invasive diagnostic tool to contain a global outbreak of malaria
- 4 September 2023
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 193 (2) , 831-832
Potential of near-infrared spectroscopy (NIRS) as a non-invasive diagnostic tool to contain a global outbreak of malaria
- Open Access
- 3 May 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (6) , 2767-2773
Comprehensive overview of human monkeypox: epidemiology, clinical features, pathogenesis, diagnosis and prevention
Monkeypox (MPX) is a zoonotic disease caused by the monkeypox virus (MPXV), belonging to the orthopoxvirus genus with a presentation resembling smallpox making it historically challenging to distinguish the disease from smallpox clinically. Since a British citizen brought MPX into the country on 6 May 2022, there have been concerns about the re-emergence of the human MPXV. Since then, the WHO has reported 92 confirmed cases and 28 suspected cases in 13 nations where MPXV was not endemic. WHO declared MPX a ‘public health emergency of international concern’ on 23 July 2022. MPXV can spread either through human-human contact or animal-human contact. Respiratory droplets, direct contact with bodily fluids, contaminated patient surroundings or objects, and skin sores from an infected person have all been linked to the disease’s transmission from one person to another. Fever, headache, lethargy, asthenia, enlargement of the lymph nodes, weariness, back pain, and myalgia are some of the symptoms that last from 2 to 5 weeks. It can be diagnosed using a range of diagnostic methods, including electron microscopy, Immunoglobulin M, enzyme-linked immunosorbent assay, polymerase chain reactions, histological analysis, immunofluorescent antibody testing, virus isolation, etc. Smallpox immunization before infection may lessen clinical symptoms and is around 85% effective in protecting from the MPXV.
- 3 May 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (6) , 2767-2773
Open AccessComprehensive overview of human monkeypox: epidemiology, clinical features, pathogenesis, diagnosis and prevention
Monkeypox (MPX) is a zoonotic disease caused by the monkeypox virus (MPXV), belonging to the orthopoxvirus genus with a presentation resembling smallpox making it historically challenging to distinguish the disease from smallpox clinically. Since a British citizen brought MPX into the country on 6 May 2022, there have been concerns about the re-emergence of the human MPXV. Since then, the WHO has reported 92 confirmed cases and 28 suspected cases in 13 nations where MPXV was not endemic. WHO declared MPX a ‘public health emergency of international concern’ on 23 July 2022. MPXV can spread either through human-human contact or animal-human contact. Respiratory droplets, direct contact with bodily fluids, contaminated patient surroundings or objects, and skin sores from an infected person have all been linked to the disease’s transmission from one person to another. Fever, headache, lethargy, asthenia, enlargement of the lymph nodes, weariness, back pain, and myalgia are some of the symptoms that last from 2 to 5 weeks. It can be diagnosed using a range of diagnostic methods, including electron microscopy, Immunoglobulin M, enzyme-linked immunosorbent assay, polymerase chain reactions, histological analysis, immunofluorescent antibody testing, virus isolation, etc. Smallpox immunization before infection may lessen clinical symptoms and is around 85% effective in protecting from the MPXV.
- Open Access
- 23 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104779
Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
- 23 September 2022
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 82, 104779
Open AccessMonkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?